Back to Journals » Breast Cancer: Targets and Therapy » Volume 3

Review

Clinical utility of the combination of lapatinib and letrozole in the management of hormone receptor-positive and HER2-positive advanced breast cancer

       
Total article views   HTML views PDF downloads Totals
9,749 Dovepress* 9,187+ 2,232 11,419
PubMed Central* 562 189 751
Totals 9,749 2,421 12,170
*Since 26 October 2011
+Since July 2016

View citations on PubMed Central and Google Scholar